Wei-Li (William) Kuan is a Principal Scientist at Talisman Therapeutics. He is responsible for leading research projects and managing project teams. Before joining Talisman, William was a Medical Research Council Innovation Fellow at the University of Cambridge and his work focussed on modelling the pathogenesis of Parkinson’s disease. He led a research team to investigate the biology driving the selective loss of specific neuronal populations in response to pathogenic seeding. He also established extensive collaborations with chemists and mathematicians to track and predict the progression of other neurodegenerative conditions including Huntington’s disease. William received his PhD degree from the University of Cambridge, where he studied the neuroprotective potential of cell therapies in Parkinson’s disease.